These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 5002728)

  • 61. Counter-immunoelectrophoresis: rapid method for detecting group-specific antigen and antibodies associated with oncogenic ribonucleic acid viruses.
    Hoekstra J; Deinhardt F
    Appl Microbiol; 1971 Dec; 22(6):1172-3. PubMed ID: 5002901
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Tumor-associated antigens in gynecologic cancer.
    DiSaia PJ
    Clin Obstet Gynecol; 1975 Dec; 18(4):87-108. PubMed ID: 765038
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Problems of tumor immunity and the possibility of immunotherapy in tumor].
    Shimoyama M
    Nihon Rinsho; 1971; 29(6):1515-29. PubMed ID: 4933610
    [No Abstract]   [Full Text] [Related]  

  • 64. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers.
    Mohr AJ; Nordquist RE; Rhoades ER; Coalson RE; Coalson JJ
    Cancer Res; 1974 Aug; 34(8):1904-7. PubMed ID: 4366936
    [No Abstract]   [Full Text] [Related]  

  • 65. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 66. Immunologic and immunotherapeutic studies with human sarcomas.
    Eilber FR; Morton DL
    Surg Forum; 1970; 21():127-9. PubMed ID: 4999008
    [No Abstract]   [Full Text] [Related]  

  • 67. Auto-antibodies in malignant disease.
    Whitehouse JM; Fairley G
    Bull Soc Sci Med Grand Duche Luxemb; 1973 Nov; 110(2):197-202. PubMed ID: 4589246
    [No Abstract]   [Full Text] [Related]  

  • 68. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW; Anderson B; Wigzell H; Fenyö EM; Klein E
    Int J Cancer; 1974 Jan; 13(1):91-104. PubMed ID: 4594340
    [No Abstract]   [Full Text] [Related]  

  • 69. [Tumor immunology].
    Cerni CM
    Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
    [No Abstract]   [Full Text] [Related]  

  • 70. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

  • 71. Immunology of virus-induced tumours.
    Sjögren HO
    Mod Trends Med Virol; 1967; 1(0):207-22. PubMed ID: 4366129
    [No Abstract]   [Full Text] [Related]  

  • 72. In vitro methods for assessment of antibody-mediated tumor immunity.
    Levy NL; Amos DB; Solovieff GV; dos Reis AP
    Natl Cancer Inst Monogr; 1972 Dec; 35():5-11. PubMed ID: 4349154
    [No Abstract]   [Full Text] [Related]  

  • 73. Nonspecific lymphocyte cytotoxicity in patients with malignant melanoma, renal cell carcinoma, and sarcomas, and in nontumor patients.
    Bukowski RM; Barna B; Deodhar SD; Hewlett JS
    Cancer; 1976 Nov; 38(5):1962-7. PubMed ID: 991109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microcytotoxicity test: detection in sarcoma patients of antibody cytotoxic to human sarcoma cells.
    Wood WC; Morton DL
    Science; 1970 Dec; 170(3964):1318-20. PubMed ID: 5273705
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Immunoperoxidase staining for Ia-like antigens in paraffin-embedded tissues from human melanoma and lung carcinoma.
    Wilson BS; Herzig MA; Lloyd RV
    Am J Pathol; 1984 Apr; 115(1):102-8. PubMed ID: 6369992
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Detection of human melanoma antigens in cell-free supernatants.
    Leong SP; Cooperband SR; Sutherland CM; Krementz ET; Deckers PJ
    J Surg Res; 1978 Apr; 24(4):245-52. PubMed ID: 347171
    [No Abstract]   [Full Text] [Related]  

  • 77. [Immunologic reactivity against cancer and possibilities of its change].
    Pasternak L; Pasternak G
    Dermatol Monatsschr; 1970; 156(5):372-7. PubMed ID: 4101547
    [No Abstract]   [Full Text] [Related]  

  • 78. Increase in preexisting cellular antigen-combining groups at different times after infection with different viruses.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1970 Oct; 67(2):731-7. PubMed ID: 4331719
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Immunologic approach to cancer.
    Mitchison NA
    Transplant Proc; 1970 Mar; 2(1):92-103. PubMed ID: 4107297
    [No Abstract]   [Full Text] [Related]  

  • 80. [Immunological exploration of cancer patients. II. Tumoral immunity].
    Cappelaere P; Demaille A; Adenis L
    Lille Med; 1973 Feb; 18(2):179-201. PubMed ID: 4581842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.